HAE FY 2018 Earnings Report — Haemonetics Corporation Revenue & Financial Results | Market Cap Arena

Haemonetics CorporationHAE

FY 2018 Earnings

Reported May 23, 2018

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2018	Prior Q	FY 2017	QoQ Change	YoY Change
Revenue	$904M	—	$886M	—	2.0%
Op. Income	$56M	—	-$19M	—	389.8%
Gross Margin	45.6%	—	42.7%	—	2.9pp
Net Margin	5.0%	—	-3.0%	—	8.0pp
EPS (Diluted)	$0.85	—	$-0.51	—	266.7%
Free Cash Flow	$146M	—	$84M	—	74.1%

Revenue Flow

Item	Amount
REVENUE	$904M
Cost of Revenue	$492M
GROSS PROFIT	$412M
R&D Expenses	$39M
Selling & Marketing	$3M
General & Administrative	$313M
SG&A Expenses	$317M
Other Expenses	$0
Operating Expenses	$356M
Cost & Expenses	$848M
OPERATING INCOME	$56M
Interest Income	$0
Interest Expense	$5M
Other Income/Expenses	$3M
INCOME BEFORE TAX	$60M
Income Tax Expense	$14M
Net Income from Continuing Ops	$46M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$46M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$46M
D&A	$89M
EBIT	$64M
EBITDA	$153M
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$904M
Cost of Revenue	$492M
GROSS PROFIT	$412M
R&D Expenses	$39M
Selling & Marketing	$3M
General & Administrative	$313M
SG&A Expenses	$317M
Other Expenses	$0
Operating Expenses	$356M
Cost & Expenses	$848M
OPERATING INCOME	$56M
Interest Income	$0
Interest Expense	$5M
Other Income/Expenses	$3M
INCOME BEFORE TAX	$60M
Income Tax Expense	$14M
Net Income from Continuing Ops	$46M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$46M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$46M
D&A	$89M
EBIT	$64M
EBITDA	$153M
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$46M
Depreciation & Amortization	$89M
Stock-Based Compensation	$13M
Deferred Income Tax	-$6M
Other Non-Cash Items	$2M
Change in Working Capital	$76M
OPERATING CASH FLOW	$220M
Capital Expenditure	-$75M
Acquisitions (Net)	$9M
Purchases of Investments	$0
Sales/Maturities of Investments	$0
Other Investing Activities	$3M
NET CASH FROM INVESTING	-$63M
Net Debt Issuance	-$61M
Common Stock Repurchased	-$100M
Common Dividends Paid	$0
Other Financing Activities	$40M
NET CASH FROM FINANCING	-$121M
FREE CASH FLOW	$146M
Net Change in Cash	$41M

Balance Sheet

Item	Amount
Cash & Equivalents	$180M
Short-Term Investments	$0
Net Receivables	$151M
Inventory	$161M
Other Current Assets	$29M
TOTAL CURRENT ASSETS	$521M
PP&E (Net)	$332M
Goodwill	$211M
Intangible Assets	$157M
Long-Term Investments	-$4M
Tax Assets	$4M
Other Non-Current Assets	$16M
TOTAL NON-CURRENT ASSETS	$716M
TOTAL ASSETS	$1.2B
Account Payables	$55M
Short-Term Debt	$194M
Deferred Revenue	$26M
Other Current Liabilities	$35M
TOTAL CURRENT LIABILITIES	$385M
Long-Term Debt	$59M
Deferred Revenue NC	-$9M
Deferred Tax Liabilities	$9M
Other Non-Current Liabilities	$34M
TOTAL NON-CURRENT LIABILITIES	$100M
TOTAL LIABILITIES	$485M
Common Stock	$523.0K
Additional Paid-In Capital	$504M
Retained Earnings	$267M
Treasury Stock	$0
Accum. Other Comp. Income	-$19M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$752M
Minority Interest	$0
TOTAL EQUITY	$752M
TOTAL LIABILITIES & EQUITY	$1.2B
Total Debt	$254M
Net Debt	$74M